136 related articles for article (PubMed ID: 29505472)
1. Cutaneous T-Cell Lymphoma, a Novel Manifestation of PDGFRA-Rearranged Neoplasm.
Behdad A; Allen P; Lu X; Zhou XA; Guitart J; Chen Q; Pro B
Am J Dermatopathol; 2018 Aug; 40(8):610-613. PubMed ID: 29505472
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature.
Zhou J; Papenhausen P; Shao H
Int J Clin Exp Pathol; 2015; 8(5):5812-20. PubMed ID: 26191303
[TBL] [Abstract][Full Text] [Related]
3. A case of nonleukemic myeloid sarcoma with FIP1L1-PDGFRA rearrangement: an unusual presentation of a rare disease.
Chen D; Bachanova V; Ketterling RP; Begna KH; Hanson CA; Viswanatha DS
Am J Surg Pathol; 2013 Jan; 37(1):147-51. PubMed ID: 23232855
[TBL] [Abstract][Full Text] [Related]
4. FIP1L1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.
Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma.
Akiely R; Almasri F; Almasri N; Abu-Ghosh A
Front Pediatr; 2022; 10():1059527. PubMed ID: 36589160
[TBL] [Abstract][Full Text] [Related]
6. Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature.
Socola F; Hawes V; Lobo RH; Sasapu A
J Glob Oncol; 2018 Sep; 4():1-4. PubMed ID: 30241197
[No Abstract] [Full Text] [Related]
7. A diagnostically difficult case of chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA effectively treated with imatinib in accelerated phase: case report.
Rodzaj M; Gałazka K; Majewski M; Zduńczyk A
Pol Arch Med Wewn; 2009 Dec; 119(12):838-41. PubMed ID: 20010473
[TBL] [Abstract][Full Text] [Related]
8. Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy.
Barraco D; Carobolante F; Candoni A; Simeone E; Piccaluga P; Tabanelli V; Fanin R
Eur J Haematol; 2014 Jun; 92(6):541-5. PubMed ID: 24460680
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and genetic features of a patient with myeloid neoplasm in association with PDGFRA and EVI1 gene rearrangements].
Han W; Chao H; Zhou M; Cen L; Chen S; He X; Lu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):93-97. PubMed ID: 28186604
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
[TBL] [Abstract][Full Text] [Related]
11. Synchronous T lymphoblastic lymphoma and myeloid neoplasm with PDGFRA rearrangement.
Pourabdollah M; Gupta M; Schimmer A; Chang H
Int J Lab Hematol; 2017 Feb; 39(1):e28-e32. PubMed ID: 28013529
[No Abstract] [Full Text] [Related]
12. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.
Rathe M; Kristensen TK; Møller MB; Carlsen NL
Pediatr Blood Cancer; 2010 Oct; 55(4):730-2. PubMed ID: 20589620
[TBL] [Abstract][Full Text] [Related]
13. A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia.
Sugimoto Y; Sada A; Shimokariya Y; Monma F; Ohishi K; Masuya M; Nobori T; Matsui T; Katayama N
Cancer Genet; 2015 Oct; 208(10):508-12. PubMed ID: 26319757
[TBL] [Abstract][Full Text] [Related]
14. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
Metzgeroth G; Walz C; Score J; Siebert R; Schnittger S; Haferlach C; Popp H; Haferlach T; Erben P; Mix J; Müller MC; Beneke H; Müller L; Del Valle F; Aulitzky WE; Wittkowsky G; Schmitz N; Schulte C; Müller-Hermelink K; Hodges E; Whittaker SJ; Diecker F; Döhner H; Schuld P; Hehlmann R; Hochhaus A; Cross NC; Reiter A
Leukemia; 2007 Jun; 21(6):1183-8. PubMed ID: 17377585
[TBL] [Abstract][Full Text] [Related]
15. Novel fusion between the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with chronic myeloid leukemia-like neoplasm: undetectable residual disease after imatinib therapy.
Cluzeau T; Lippert E; Cayuela JM; Maarek O; Migeon M; Noguera ME; Dombret H; Rea D
Eur J Haematol; 2015 Nov; 95(5):480-3. PubMed ID: 25941032
[TBL] [Abstract][Full Text] [Related]
16. PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia.
Huang Q; Snyder DS; Chu P; Gaal KK; Chang KL; Weiss LM
Leukemia; 2011 Feb; 25(2):371-5. PubMed ID: 21304535
[No Abstract] [Full Text] [Related]
17. Complete response of myeloid sarcoma with FIP1L1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.
Tang TC; Chang H; Chuang WY
Acta Haematol; 2012; 128(2):83-7. PubMed ID: 22722648
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of cytogenetics and molecular biology in patients with eosinophilia].
Qu SQ; Ai XF; Li CW; Li QH; Xu ZF; Qin TJ; Zhang Y; Xiao ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1216-20. PubMed ID: 23114151
[TBL] [Abstract][Full Text] [Related]
19. PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review.
Andrei M; Bandarchuk A; Abdelmalek C; Kundra A; Gotlieb V; Wang JC
Am J Case Rep; 2017 Feb; 18():173-180. PubMed ID: 28209946
[TBL] [Abstract][Full Text] [Related]
20. Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancy.
Capovilla M; Cayuela JM; Bilhou-Nabera C; Gardin C; Letestu R; Baran-Marzak F; Fenaux P; Martin A
Eur J Haematol; 2008 Jan; 80(1):81-6. PubMed ID: 18028420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]